Nirmala Bhoo Pathy shared a post by Ophira Ginsburg on LinkedIn:

“Climbing the Authorship Ladder! First and last author positions in global cancer research signify equity and on a more personal note, career advancement.

By analyzing trends in first and last authorships in published literature, a study led by the ever-brilliant and bold Miriam Mutebi and Ophira Ginsburg has shed light on the extent of gender disparities in global cancer research.

This important work underscores the need for efforts to promote gender equity in global oncology research and prioritisation of interventions aimed at increasing the representation of women in these key author positions.

Congratulations to the amazing team for this brilliant piece- Nazik Hammad, Erica Liebermann, Verna Vanderpuye, Winnie So, Richard Sullivan, Julie S. Torode and Grant Lewison.”

Quoting Ophira Ginsburg’s post:

“Just out! Our new paper on sex and authorship in global cancer research, led by the amazing amazing Miriam Mutebi.

Key findings:

• Our analysis of 56 countries’ outputs, in 2009, revealed that females were the first authors in 37.2% and last authors in 23.3% of papers. In 2019, females were the first author in 41.6% and last author in 29.4% of papers.
• From 2009 to 2019, the highest proportion of females as first and last authors were from low-income and middle-income countries in Latin America and Eastern Europe.
• Females were more likely to publish in lower impact journals and were less likely to be cited compared to males.

Stay tuned for more from The Lancet Commission on Women, Power, and Cancer!”

Source: Nirmala Bhoo Pathy/LinkedIn and Ophira Ginsburg/LinkedIn

Nirmala Bhoo-Pathy is as a Professor of Epidemiology in the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, and practices as a public health physician in Universiti Malaya Medical Centre, Malaysia. She is also a visiting scholar at Queen’s University Belfast, United Kingdom since 2014. Dr Bhoo Pathy’s career is focused on optimizing life after cancer in resource-limited settings through research and advocacy. Dr Bhoo Pathy was the principal investigator of phase III of the ASEAN CosTs In ONcology (ACTION) study, comprising close to 10,000 cancer patients from eight low-and middle-income member countries of the Association of South East Asian Nations (ASEAN). She currently serves in two Lancet Commissions: the Lancet Commission on Women and Cancer and the Lancet Commission on Cancer and Health Systems. As the founder and scientific lead of a solution-oriented research group ‘Well with Cancer in Malaysia (WeCan@MY) https://spm.um.edu.my/wecan@my/ in the Department of Social and Preventive Medicine, Nirmala Bhoo-Pathy currently oversees a wide range of studies on cancer care, cancer control and cancer policy, locally and globally.

Ophira Ginsburg is a Canadian medical oncologist, humanitarian, and global cancer advocate. Currently, she is the Senior Scientific Officer and Senior Advisor for Clinical Research at the US NCI’s Center for Global Health. Formerly based at the University of Toronto, Canada, she was a Medical Officer at the World Health Organization (WHO) Headquarters in Geneva, Switzerland, and has served as an ad hoc consultant to several UN agencies. She is the co-chair of The Lancet Commission on Women and Cancer. In 2022, Dr. Ginsburg won the American Society of Clinical Oncology’s Humanitarian Award.

About OncoDaily 

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.